This site is intended for healthcare professionals only
LoginRegister
Consumer Court Holds Max Hospital Liable for Deficiency in Service, Slaps CompensationPharma Firm Ignored Safety Gaps Before Deadly Blast, Paid Rs 32 Cr To Victims, Parliament Informed
GSK, LTZ collaborate to advance novel myeloid cell engagers in oncologyGSK Blenrep combos approved in EU for treatment of relapsed/refractory multiple myeloma
NPPA Warns Drugmakers Against Arbitrary Pricing, Calls for MRP UniformityNPPA Warns Drugmakers Against Arbitrary Pricing, Calls for MRP Uniformity
NPPA Committee Asks Intas to Clarify Patent Discrepancy in Clozapine ER Pricing PleaNPPA Committee Asks Intas to Clarify Patent Discrepancy in Clozapine ER Pricing Plea
Shree Ramkrishna Exports forays into pharma space with launch of Kriam PharmaIndia Cuts API Imports, Disburses Rs 1,008 Cr Under PLI Schemes, Parliament Told
Bail grantedPCI President Montu Patel granted pre-arrest bail in corruption case
Alembic Pharma gets USFDA nod for angina drug Diltiazem HydrochlorideAlembic Pharma gets USFDA nod for anticonvulsant drug Carbamazepine Extended Release
Tamil Nadu cancels licence of Sresan Pharma, orders shutdownLicences of 2 pharma stores suspended for unethical trade practices
Zydus gets nod from China NMPA for Major Depressive Disorder drug Venlafaxine ER16912 Jan Aushadhi Kendras opened till June 30: Minister
CDSCO Panel Directs Mankind Pharma to Conduct Phase I Trial of Sintilimab Before Phase III LaunchMankind Pharma incorporates wholly owned subsidiary in Sri Lanka
No Trial Waiver: CDSCO Panel Directs Sun Pharma to Run Phase III Study for Somatropin Liquid Injection Citing Lack of India-Specific DataSun Pharma Agrees To Rs 1,654 Cr Settlement In U.S. Pricing Row
Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun PharmaNo Special Price for Novel Pack: NPPA Panel Turns Down Sun Pharma's Amoxicillin-Clavulanic...
X